Laxmikanth CHATRA, Jasmine Shanthi KAMATH

Identification of Potentially Malignant Oral Lesions

Ağız kanseri sıklığı her gün eklenen yeni hastalar ile çok yüksek bir insidansa ulaşmıştır. Kansere neden olan koşullar en erken zamanda belirlenmelidir. Halihazırda kullanılan teşhis araçları, lezyonları morfolojik değişikliğe uğratan ve frank malignitenin önceden belirlendiği bir aşamada tanımlamayı amaçlamaktadır. Alışkanlıkla ilişkili lezyonların malign potansiyelini teşhis etmek ve giderek artan sayıda oral kanser vakalarını önlemek için yeni biyolojik belirteçleri belirlemek büyük aciliyet arz etmektedir. Bu yazıda kullanılan mevcut teşhis araçları, eksiklikleri ve gelecekte gerçek olabilecek proteomik yönelik eğilimler ile ele alınmıştır

Potansiyel Malign Oral Lezyonların Belirlenmesi

Oral cancer has reached its magnificent height with newer victims being added everyday into its registry. Conditions that predispose to cancer must be identified at its earliest. Diagnostic aids that are currently employed, identify lesions with morphological alteration at a stage where frank malignancy has already set in. There seems to be a great urgency to identify novel biomarkers to diagnose the malignant potential in these habit-associated lesions and prevent the ever-increasing number of oral cancer cases. The following review addresses the current diagnostic aids used, with its shortcomings and future trends in proteomics, which should become a reality

PDF

___

1. Sankaranarayanan R, Ramadas K, Thomas G. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet.2005;365:1927–33.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74- 108.
3. Sankaranarayanan R, Duffy SW., Nair MK., Padmakumary G, Day, NE. Tobacco and alcohol as risk factors in cancer of the larynx in Kerala, India. Int J Cancer.1990;45:879-82.
4. Arduino PG, Carrozzo M, Chiecchio A, Broccoletti R, Tirone F, Borra E et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg.2008;66:1570-9.
5. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309-16.
6. Mehrotra R, Gupta A, Singh M and Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer.2006;5:11.
7. Morse DE, Psoter WJ, Cuadrado L, Jean YA, Phelan J, Mittal K et al. A deficit in biopsying potentially premalignant oral lesions in Puerto Rico. Cancer Detect Prev.2009;32:424-30.
8. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. New Delhi, International Agency for Research on Cancer Press,2005.
9. Warnakulasuriya S, Johnson NW, Van Der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med.2007;36:575-80.
10. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770-80.
11. Mehta FS, Pindborg JJ, Gupta PC, Daftary DK. Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer.1969;24:832-49.
12. Banoczy J. Follow up studies in oral leukoplakia. J Maxillofac Surg.1977;5:69-75.
13. Bagan JV, Jimenez Y, Murillo J, Gavalda C, Poveda R, Scully C et al. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection. J Oral Maxillofac Surg. 2007;65:46-9.
14. Johnson NW, Warnakulasuriya S, Gupta PC, Dimba E, Chindia M, Otoh ECet al. Global inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res.2011 23: 237–46.
15. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. "Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from the Netherlands." Oral Oncol. 1998;34:270-5.
16. World Health Organization Collaborating Center for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol.1978;46:518-39.
17. Prasanna Kumar Rao J. Potentially malignant lesion – oral leukoplakia. Global Advanced Research Journal of Medicine and Medical Sciences.2012;1:286-91.
18. Reibel J. "Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics." Crit Rev Oral Biol Med.2003;14: 47-62.
19. Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer.1975;36:1021-8.
20. Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC. Oral submucous fibrosis in India: a new epidemic? Natl Med J India. 1998;11:113-6.
21. Chatra L, Khan S.Pathogenesis of oral submucous fibrosis. J of Can Res Therap.2012;8:199-203.
22. Paymaster JC. Cancer of the buccal mucosa: a clinical study of 650 cases in Indian patients. Cancer.1956;9:431-5.
23. Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, Jalnawalla PN et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol.1980;8:283-333.
24. Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS. Oral submucous fibrosis as a precancerous condition. Scand J Dent Res.1984;92:224-9.
25. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol. 1985;13:340-1.
26. Sugerman PB, Satterwhite K, Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol. 2000;142:449-56.
27. Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med.2002;13:350-65.
28. Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med.2007;36:25-9.
29. MattssonU,JontellM,HolmstrupP.Orallichenplanusandmalignant transformation: Is a recall of patients justified? Crit Rev Oral Biol Med.2002;13:390-6.
30. Roosaar A, Yin L, Sandborgh-Englund G, Nyren O, Axell T. On the natural course of oral lichen lesions in a Swedish population-based sample. J Oral Pathol Med.2006;35:257-61.
31. van der Meij EH, Mast H, Van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol.2007;43:742-8.
32. Lanfranchi-Tizeira HE, Aguas SC, Sano SM. Malignant transformation of atypical oral lichen planus: A review of 32 cases. Med Oral.2003;8:2-9.
33. Ortiz GM, Pierce AM, Wilson DF. Palatal changes associated with reverse smoking in Filipino women. Oral Dis.1996;2:232-7.
34. Smith JF, Mincer HA, Hopkins KP, Bell J. Snuff-dipper’s lesion. A cytological and pathological study in a large population. Arch Otolaryngol.1970;92:450-6.
35. Sankaranarayanan R, Ramadas K, Thomas G. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet.2005;365:1927-33.
36. Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol.2004;40:264-73.
37. Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, et al. Early findings from a community-based, cluster- randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer.2000;88:664-73.
38. Mathew B, Sankaranarayanan R, Wesley R, Nair MK. Evaluation of mouth self-examination in the control of oral cancer. Br J Cancer.1995;71:397-9.
39. Scott SE, Rizvi K, Grunfeld EA, McGurk M. Pilot study to estimate the accuracy of mouth selfexamination in an at-risk group. Head Neck.2010;32:1393-401.
40. Eisen D, Frist S. The relevance of the high positive predictive value of the oral brush biopsy. Oral Oncol.2005;41:753-5.
41. Svirsky JA, Burns JC, Carpenter WM, Cohen DM, Bhattacharyya I, Fantasia JE et al. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent. 2002;50:500-3.
42. Bhoopathi V, Kabani S, Mascarenhas AK. Low positive predictive value of the oral brush biopsy in detecting dysplastic oral lesions. Cancer.2009;115:1036-40.
43. Warnakulasuriya KA, Johnson NW. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med.1996;25:97-103.
44. Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2001;91:535-40.
45. Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.1998;85:444- 6.
46. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol.2008;44:538-44. 89.
47. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg.2007;65:424-6. 48. AwanKH, MorganPR, WarnakulasuriyaS. Utility of chemiluminescence (ViziLiteTM) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med. 2011;40:541-4.
49. Awan K.H, Morgan P.R, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscopeTM) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol.2011;47:274-7.
50. Smith PW, Holtzman J, Epstein J, Le A. Optical diagnostics in the oral cavity: an overview. Oral Diseases. 2010;16:717–28.
51. Lucchese A, Gentile E, Romano A, Maio C, Laino L, Serpico R. The potential role of in vivo reflectance confocal microscopy for evaluating oral cavity lesions: a systematic review. J Oral Pathol Med. 2016;45:723-9.
52. Maitland KC, Gillenwater AM, Williams MD, El-Naggar AK, Descour MR, Richards-Kortum RR. In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope. Oral Oncol.2008;44:1059–66.
53. White WM, Rajadhyaksha M, Gonz alez S, Fabian RL, Anderson RR. Noninvasive imaging of human oral mucosa in vivo by confocal reflectance microscopy. Laryngoscope. 1999;109:1709– 17.
54. Bano S, David MP, Indira AP. Salivary biomarkers for oral squamous cell carcinoma: an overview. IJSS Case Reports Reviews.2015;1:39-45.
55. Almeida P, Lima A. Saliva Composition and Functions. J of Contemp Dent Pract 2008;9:1-11.
56. Castagnola M, Picciotti PM, Messana I, Fanali C, Fiorita A, Cabras T, Calò L, Pisano E, Passali GC, Iavarone F, Paludetti G, Scarano E. Potential applications of human saliva as diagnostic fluid. Acta Otorhinolaryngol Ital. 2011;31:347-57.
57. Bandhakavi S, Stone MD, Onsongo G, Van Riper SK, Griffin TJ. A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J Proteome Res. 2009;3:5590–60.
58. Chiappin S, Antonelli G, Gatti R, De Palo EF. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta.2007;383:30-40.
59. Messana I, Inzitari R, Fanali C, Cabras T, Castagnola M. Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us? J Sep Sci. 2008;31:1948-63.
60. Rathnayake N, Sigvard A. Salivary biomarkers for detection of systemic diseases. PLOS One. 2013;8:1-5.
61. Jou YJ, Lin CD, Lai CH, Chen CH, Kao JY , Chen SY et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. AnalChimActa. 2010;681:41-8.
62. Boyle JO, Mao L. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg. 1994;168:429-32.
63. Graves PR, Haystead TAJ. Molecular biologist’s guide to proteomics. Microbiol Mol Biol. Rev.2002;66:39-63.
64. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R et al.,The current state of twodimensional electrophoresis with immobilized pH gradients. Electrophoresis. 2000;21:1037–53.
65. Hanash S. Disease proteomics. Nature.2003;422:226-32.

ISSN: 1300-3755
Yayın Aralığı: Yılda 4 Sayı
Başlangıç: 1992
Yayıncı: Çukurova Üniversitesi Tıp Fakültesi

Arşiv